This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...
As previously mentioned in Zika communications distributed on September 21 and October 12, 2018; ord...
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...
At CTS, we understand the impact converting to the Ortho viral marker platform has on your operation...